✦ LIBER ✦

Performance evaluation of a new chemiluminescent assay for prostate specific antigen

✍ Scribed by Amitava Dasgupta; Alice Wells; Pradip Datta

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 46 KB
Volume: 14
Category: Article
ISSN: 0887-8013
DOI: 10.1002/1098-2825(2000)14:4<164::aid-jcla5>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Performance evaluation of a new chemilum

Performance evaluation of a new chemiluminescent cardiac troponin I assay

✍ Amitava Dasgupta; Loretta Chow; Lupe Nazareno; Gretie Tso; Pradip Datta 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

Standardization of immunoassays for pros

Standardization of immunoassays for prostate-specific antigen. A problem of prostate-specific antigen complexation or a problem of assay design?

✍ Howard C. B. Graves 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 1 views

Prostate-specific antigen: A surrogate e

Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer?

✍ Schr�der, Fritz H.; Kranse, Ries; Barbet, Nik; Hop, Wim C.J.; Kandra, Albert; La 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 2 views

BACKGROUND. An endpoint for clinical trials of prostate cancer which simplifies traditional endpoints (response of measurable lesions, progression rates, and death) is urgently needed. This is especially true for hormone-unresponsive disease, for which many new drugs are presently in a development p

Evaluation of prostatic specific antigen

Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer

✍ Bernard Candas; Lionel Cusan; Jose-Luis Gomez; Pierre Diamond; Raul E. Suburu; J 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 1 views

## BACKGROUND. The 11,811 first visits and 46,751 annual follow-up visits performed since 1988 were analyzed in order to assess the efficacy of serum prostatic specific antigen (PSA) and digital rectal examination (DRE) for diagnosis of prostate cancer. METHODS. At first visit, screening included

Induction of human cytotoxic T lymphocyt

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen

✍ Xue, Bao-Hua; Zhang, Yong; Sosman, Jeffrey A.; Peace, David J. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

Prostate-specific antigen (PSA), a tissue-specific protein expressed by most adenocarcinomas of the prostate, might be a useful target for T-cell-mediated immunotherapy of prostate cancers. The current study examined whether it is possible to elicit human cytotoxic T lymphocytes (CTL) with specifici

Radiotherapy for localized prostate carc

Radiotherapy for localized prostate carcinoma : The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen

✍ Juanita M. Crook; Yasir A. Bahadur; R. Gregory Bociek; Gad A. Perry; Susan J. Ro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Background: The objective of this study was to correlate the failure pattern of localized prostate carcinoma after radiotherapy (rt) with pretreatment (pretx) psa and post-rt nadir psa, using systematic biopsies and serum psa in the assessment of outcome. ## Methods: From january 1990 to febru